The present study demonstrates the capacity of small kinase Akt and JNK inhibitors, 10-DEBC and SP, to potentiate the toxicity of MD and AA+MD, well-known oxidative stress generators, towards GBM cells in vitro. This evidence concerns the gene AKT1 and glioblastoma.